ZSTK474, a novel PI3K inhibitor, modulates human CD14+ monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis

被引：0

作者：

Zhenyi Xue

Wen Li

Huafeng Wang

Biao Huang

Zhenzhen Ge

Chao Gu

Ying Liu

Kai Zhang

Juhong Yang

Rong Han

Meiyu Peng

Yan Li

Da Zhang

Yurong Da

Zhi Yao

Rongxin Zhang

机构：

[1] Tianjin Medical University,Laboratory of Immunology and Inflammation, Research Center of Basic Medical Science

[2] Tianjin Medical University,Department of Immunology, Basic Medical College

[3] Tianjin Medical University,Tianjin Key Laboratory of Cellular and Molecular Immunology

[4] Tianjin Medical University,Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China

[5] Tianjin First Central Hospital,Department of Neurology

[6] Tianjin Medical University,Tianjin Metabolic Diseases Hospital

[7] Tianjin Medical University,School of Medical Imaging

[8] Tianjin Medical University,Research Center of Basic Medical Science

来源：

Journal of Molecular Medicine | 2014年 / 92卷

关键词：

ZSTK474; PI3K; Dendritic cells; Th17 cells; Experimental autoimmune encephalomyelitis; Multiple sclerosis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1057 / 1068

页数：11

共 172 条

[1] Ruckle T(2006)PI3Kgamma inhibition: towards an ‘aspirin of the 21st century’? Nat Rev Drug Discov 5 903-918
[2] Schwarz M(2002)Phosphoinositide 3-kinase in immunological systems Semin Immunol 14 7-18
[3] Rommel C(2007)PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol 7 191-201
[4] Fruman DA(2010)Inhibition profiles of phosphatidylinositol 3-kinase inhibitors against PI3K superfamily and human cancer cell line panel JFCR39 Eur J Cancer 46 1111-1121
[5] Cantley LC(2000)In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002) Clin Cancer Res 6 880-886
[6] Rommel C(2004)Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling Mol Cancer Ther 3 763-772
[7] Camps M(2006)Antitumor activity of ZSTK474: a new phosphatidylinositol 3-kinase inhibitor J Natl Cancer Inst 98 545-556
[8] Ji H(2007)ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms Cancer Sci 98 1638-1642
[9] Kong D(2008)Phosphatidylinositol 3-kinase inhibitors: promising drug candidates for cancer therapy Cancer Sci 99 1734-1740
[10] Dan S(2009)Effect of ZSTK474: a novel phosphatidylinositol 3-kinase inhibitor on DNA-dependent protein kinase Biol Pharm Bull 32 297-300